AONC OTC
American Oncology Network, Inc.
1W: +0.0%
1M: +10.0%
3M: +10.0%
YTD: -8.3%
1Y: +29.4%
3Y: -16.0%
5Y: +12.7%
$11.00
+1.00 (+10.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1.8B
+37.5% ▲
4Y CAGR: +24.8%
Gross Profit
$118M
+42.3% ▲
4Y CAGR: +15.6%
Operating Income
-$17M
+64.5% ▲
Net Income
-$4M
+28.3% ▲
EPS (Diluted)
$-0.69
+49.3% ▲
EBITDA
$2M
+104.6% ▲
4Y CAGR: -48.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $725M | $944M | $1.1B | $1.3B | $1.8B |
| YoY Growth | +0.0% | +30.2% | +21.8% | +11.3% | +37.5% |
| Cost of Revenue | $659M | $866M | $1.1B | $1.2B | $1.6B |
| Gross Profit | $66M | $78M | $95M | $83M | $118M |
| Gross Margin | 9.1% | 8.3% | 8.3% | 6.5% | 6.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $44M | $77M | $87M | $101M | $134M |
| Operating Expenses | $44M | $77M | $90M | $132M | $135M |
| Operating Income | $22M | $911K | $6M | -$49M | -$17M |
| Operating Margin | 3.0% | 0.1% | 0.5% | -3.8% | -1.0% |
| Interest Expense | $1M | $1M | $3M | $6M | $7M |
| Income Before Tax | $21M | $355K | $3M | -$63M | -$24M |
| Tax Expense | -$783K | $460K | $0 | $384K | $2M |
| Net Income | $22M | -$105K | $3M | -$6M | -$4M |
| Net Margin | 3.0% | -0.0% | 0.2% | -0.4% | -0.2% |
| EPS (Diluted) | $0.74 | $-0.00 | $0.06 | $-1.36 | $-0.69 |
| EBITDA | $26M | $8M | $23M | -$39M | $2M |
| Shares Outstanding | 30M | 42M | 42M | 7M | 13M |